Subtopic Deep Dive
STAT3 Transcriptional Targets in Cancer
Research Guide
What is STAT3 Transcriptional Targets in Cancer?
STAT3 transcriptional targets in cancer are genes directly regulated by the STAT3 transcription factor that promote oncogenesis, survival, proliferation, and metastasis in various malignancies.
STAT3 activates targets including c-Myc, Bcl-xL, VEGF, and MMPs via cytokine signaling in tumors (Carpenter and Lo, 2014; 515 citations). Research maps these regulons using ChIP-seq and identifies super-enhancer dependencies driving oncogene addiction. Over 20 key targets relevant to human cancers have been cataloged (Carpenter and Lo, 2014).
Why It Matters
STAT3 targets like c-Myc and VEGF drive angiogenesis and tumor growth, informing therapies targeting STAT3-dependent cancers (Carpenter and Lo, 2014). In lymphomas, STAT3 mutations activate targets promoting γδ-T and NK cell malignancies (Küçük et al., 2015; 376 citations). Hematopoietic cancers show STAT3/STAT5 signaling remodeling chromatin at target loci, revealing lineage-specific vulnerabilities (Wingelhofer et al., 2018; 236 citations). These regulons guide inhibitor development like JAK/STAT blockers in clinical trials (Hu et al., 2021; 2165 citations).
Key Research Challenges
Mapping lineage-specific targets
STAT3 cistromes vary by cancer type, complicating universal regulon identification (Carpenter and Lo, 2014). ChIP-seq reveals context-dependent binding, but enhancer hijacking requires CRISPR validation (Wingelhofer et al., 2018). Over 515-cited works highlight gaps in tumor-specific target atlases.
Distinguishing direct vs indirect regulation
STAT3 induces secondary targets via feedback loops, blurring direct effects (Morris et al., 2018; 844 citations). Positive feedback circuits amplify IFN-stimulated genes overlapping STAT3 targets (Michalska et al., 2018; 316 citations). CRISPR screens needed to confirm causality.
Therapeutic targeting of super-enhancers
STAT3-dependent tumors rely on super-enhancers at targets like Bcl-xL, but inhibitors face resistance (Galoczová et al., 2018; 268 citations). Mutation-driven activation in lymphomas evades blockade (Küçük et al., 2015). Chromatin remodeling studies show persistent dependencies (Wingelhofer et al., 2018).
Essential Papers
The JAK/STAT signaling pathway: from bench to clinic
Xiaoyi Hu, Jing Li, Maorong Fu et al. · 2021 · Signal Transduction and Targeted Therapy · 2.2K citations
The molecular details of cytokine signaling via the JAK/STAT pathway
Rhiannon Morris, Nadia J. Kershaw, Jeffrey J. Babon · 2018 · Protein Science · 844 citations
Abstract More than 50 cytokines signal via the JAK/STAT pathway to orchestrate hematopoiesis, induce inflammation and control the immune response. Cytokines are secreted glycoproteins that act as i...
STAT3 Target Genes Relevant to Human Cancers
Richard L. Carpenter, Hui‐Wen Lo · 2014 · Cancers · 515 citations
Since its discovery, the STAT3 transcription factor has been extensively studied for its function as a transcriptional regulator and its role as a mediator of development, normal physiology, and pa...
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells
Can Küçük, Bei Jiang, Xiaozhou Hu et al. · 2015 · Nature Communications · 376 citations
Lymphomas arising from NK or γδ-T cells are very aggressive diseases and little is known regarding their pathogenesis. Here we report frequent activating mutations of STAT3 and STAT5B in NK/T-cell ...
LEF-1 and TCF-1 orchestrate TFH differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6
Youn Soo Choi, Jodi A. Gullicksrud, Shaojun Xing et al. · 2015 · Nature Immunology · 319 citations
A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses
Agata Michalska, Katarzyna Błaszczyk, Joanna Wesoły et al. · 2018 · Frontiers in Immunology · 316 citations
Interferon (IFN)-I and IFN-II both induce IFN-stimulated gene (ISG) expression through Janus kinase (JAK)-dependent phosphorylation of signal transducer and activator of transcription (STAT) 1 and ...
Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway
Nancy Au-Yeung, Roli Mandhana, Curt M. Horvath · 2013 · JAK-STAT · 297 citations
STAT1 and STAT2 proteins are key mediators of type I and type III interferon (IFN) signaling, and are essential components of the cellular antiviral response and adaptive immunity. They associate w...
Reading Guide
Foundational Papers
Start with Carpenter and Lo (2014; 515 citations) for comprehensive target catalog, then Au-Yeung et al. (2013; 297 citations) for STAT pathway regulation context.
Recent Advances
Study Wingelhofer et al. (2018; 236 citations) on chromatin remodeling, Küçük et al. (2015; 376 citations) on lymphoma mutations, Hu et al. (2021; 2165 citations) for clinical translation.
Core Methods
ChIP-seq for cistrome mapping, CRISPR for target validation, RNA-seq for regulon expression, mutation sequencing for pathway activation (Morris et al., 2018).
How PapersFlow Helps You Research STAT3 Transcriptional Targets in Cancer
Discover & Search
Research Agent uses searchPapers('STAT3 transcriptional targets cancer ChIP-seq') to retrieve Carpenter and Lo (2014; 515 citations), then citationGraph reveals downstream works like Küçük et al. (2015). exaSearch uncovers enhancer hijacking papers, while findSimilarPapers expands to STAT3 regulons in lymphomas.
Analyze & Verify
Analysis Agent runs readPaperContent on Carpenter and Lo (2014) to extract 20+ target genes, then verifyResponse with CoVe cross-checks claims against Hu et al. (2021). runPythonAnalysis processes ChIP-seq citation counts via pandas for statistical significance; GRADE scores evidence strength for c-Myc regulation.
Synthesize & Write
Synthesis Agent detects gaps in lineage-specific regulons via contradiction flagging across Wingelhofer et al. (2018) and Küçük et al. (2015). Writing Agent uses latexEditText for target network diagrams, latexSyncCitations for 515-cited refs, and exportMermaid for STAT3-c-Myc enhancer graphs.
Use Cases
"Extract STAT3 target genes from lymphoma papers and plot co-occurrence heatmap."
Research Agent → searchPapers('STAT3 targets lymphoma') → Analysis Agent → readPaperContent(Küçük 2015) + runPythonAnalysis(pandas heatmap of targets c-Myc Bcl-xL) → CSV export of gene co-occurrences.
"Write LaTeX review section on STAT3 super-enhancers in cancer."
Synthesis Agent → gap detection(Carpenter 2014 + Wingelhofer 2018) → Writing Agent → latexEditText('STAT3 regulon review') → latexSyncCitations → latexCompile → PDF with diagrams.
"Find GitHub repos analyzing STAT3 ChIP-seq datasets."
Research Agent → searchPapers('STAT3 ChIP-seq cancer') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → R/Bioconductor scripts for peak calling.
Automated Workflows
Deep Research workflow scans 50+ JAK/STAT papers via searchPapers → citationGraph → structured report ranking STAT3 targets by citation impact (Hu et al., 2021). DeepScan applies 7-step CoVe to verify Carpenter (2014) claims against recent mutations (Küçük, 2015). Theorizer generates hypotheses on STAT3 enhancer hijacking from regulon synthesis.
Frequently Asked Questions
What defines STAT3 transcriptional targets in cancer?
Genes directly bound and activated by STAT3, such as c-Myc, Bcl-xL, VEGF, MMPs, promoting survival and metastasis (Carpenter and Lo, 2014).
What methods identify these targets?
ChIP-seq maps STAT3 cistromes; CRISPR screens validate functional regulation (Wingelhofer et al., 2018). Citation analyses confirm key targets across 515+ studies.
What are key papers?
Carpenter and Lo (2014; 515 citations) catalogs cancer-relevant targets; Küçük et al. (2015; 376 citations) links mutations to lymphomas; Hu et al. (2021; 2165 citations) reviews JAK/STAT clinic relevance.
What open problems exist?
Lineage-specific regulons, super-enhancer dependencies, and resistance to inhibitors remain unresolved (Galoczová et al., 2018; Wingelhofer et al., 2018).
Research Cytokine Signaling Pathways and Interactions with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching STAT3 Transcriptional Targets in Cancer with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers